Paper25622293
Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy.
Ding DC and 3 others. Cell Transplant, 2015. Cited by 459 papers, by iCite.
Cite this record
ConductScience Library. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Papers, record 25622293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25622293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell- and Tissue-Based Therapy | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Umbilical Cord | Major topic |
| Animals | |
| Biomarkers | |
| Cell Differentiation | |
| Disease Models, Animal | |
| Humans | |
| Immunomodulation | |
| Mesenchymal Stem Cell Transplantation | |
| Neoplasms |
Source PubMed
Cited by345
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 459 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984625 | Human umbilical cord mesenchymal stromal cells and their small extracellular vesicles modulate host responses to titanium-coated polypropylene mesh in the vaginal wall of rats. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42984625 | PubMed |
| 42982807 | The germ layer: foundation of mesenchymal stem cell therapeutic destiny. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42982807 | PubMed |
| 42794753 | Characterization of Umbilical Cord Mesenchymal Stromal Cells Overexpressing Klotho and In Vitro Anti-Aging Efficacy of Their Derived Extracellular Vesicles. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794753 | PubMed |
| 42569257 | Human umbilical cord mesenchymal stem cell exosomes inhibit proliferation and promote apoptosis in an in vitro model of keloid. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42569257 | PubMed |
| 42539313 | Photobiomodulation Therapy for Traumatic Spinal Cord Injury: Current Evidence and Future Directions. | Neurotrauma Rep | 2026 | https://conductscience.org/library/papers/42539313 | PubMed |
| 42458609 | Biomimetic scaffolds based on stem cells for neural tissue engineering: a review. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42458609 | PubMed |
| 42337126 | 1,8-Cineole Promotes the Proliferation of Neural Stem Cells and Inhibits Oxidative Damage Induced by Ischemic Stroke via the Wnt/β-Catenin Signaling Pathway. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42337126 | PubMed |
| 42100417 | VA/VHAG alternating consolidation regimen combined with umbilical cord blood and mesenchymal stem cell infusion for the treatment of high-risk MDS patients who are unfit for transplantation: a case report and literature review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42100417 | PubMed |
| 42089052 | Exosomes as regenerative therapeutics for spinal cord injury: mechanisms and clinical prospects. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42089052 | PubMed |
| 42080067 | Identifying key bioprocess variables using explainable machine learning to enhance culture efficiency and viability of umbilical cord-derived mesenchymal stem cells. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42080067 | PubMed |
| 42026664 | Investigation of the clinical efficacy of mesenchymal stem cells in combination with monoclonal antibody therapy against feline panleukopenia. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42026664 | PubMed |
| 41657951 | Integrated cryopreservation-thawing-transplantation platform for neural stem cell-based spinal cord injury repair. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41657951 | PubMed |
| 41645206 | Mitochondrial protein-enriched artificial nanovesicles: mitochondrial recovery and antioxidation for diabetic wound treatment. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41645206 | PubMed |
| 41625138 | A case report on nebulized human umbilical cord mesenchymal stem cell-derived exosome therapy for asthma and chronic obstructive pulmonary disease: A preliminary clinical evaluation. | SAGE Open Med Case Rep | 2026 | https://conductscience.org/library/papers/41625138 | PubMed |
| 41557127 | Therapeutic potential of umbilical cord-derived mesenchymal stem/stromal cells versus their conditioned media on treatment of polycystic ovary In-vivo. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41557127 | PubMed |
| 41528668 | Human Umbilical Cord-Derived Mesenchymal Stem Cells-Involved Strategies: Advancing Tendon Injuries Therapy Towards Clinical Translation. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41528668 | PubMed |
| 41510757 | Mechanism of human umbilical cord mesenchymal stem cell-derived exosomes in alleviating neuropathic pain in CCI rats. | Mol Pain | 2026 | https://conductscience.org/library/papers/41510757 | PubMed |
| 41488862 | Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Spinal Cord Injury. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41488862 | PubMed |
| 41466394 | Intra-articular injection of umbilical cord-derived mesenchymal stem cells is safe and effective for moderate to severe knee osteoarthritis with synovitis: a double‑blinded and randomized controlled trial. | BMC Musculoskelet Disord | 2025 | https://conductscience.org/library/papers/41466394 | PubMed |
| 41444972 | The roles and clinical applications of mesenchymal stem cells and their exosomes in hematologic diseases. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41444972 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25622293
GET https://conductscience.org/api/papers/v1/25622293/cited_by?page=2